Issue 46, 2020

Ir–Ho bimetallic complex-mediated low-dose radiotherapy/radiodynamic therapy in vivo

Abstract

We report a bimetallic complex [Ir4Ho2(pq)8(H2dcbpy)4(OAc)2] (denoted as Ir4Ho2, pq = 2-phenylquinoline, H2dcppy = 2,2′-bipyridine-3,3′-dicarboxylic acid) and its application for radiotherapy/radiodynamic therapy (RT/RDT). In a tumor xenograft mouse model, Ir4Ho2 exerted a tumor-suppressive effect through efficient low-dose RT/RDT.

Graphical abstract: Ir–Ho bimetallic complex-mediated low-dose radiotherapy/radiodynamic therapy in vivo

Supplementary files

Article information

Article type
Communication
Submitted
12 Apr 2020
Accepted
12 May 2020
First published
13 May 2020

Chem. Commun., 2020,56, 6193-6196

Ir–Ho bimetallic complex-mediated low-dose radiotherapy/radiodynamic therapy in vivo

C. Wang, T. Zhai, J. Liu, H. Yang, Y. Sun, Z. Zhou, Q. Zhao and S. Yang, Chem. Commun., 2020, 56, 6193 DOI: 10.1039/D0CC02641G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements